KU ASH 2019 Review: Current Updates in Hematologic Diseases
Avatar

KU ASH 2019 Review on Benign Hematology: New FDA Approvals, 2nd-Line cITP After Steroids Gene Therapy for Hemophilia B, ASH Guidelines

By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Penelope Harris
By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Penelope Harris
96 views
February 24, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
30:41
Icahn School of Medicine at Mount Sinai

How to Approach Anemia

Feat. C. Cromwell
42:10
Insights from 2023 ASH Annual Meeting

Highlights in Red Cell and Platelet Disorders From ASH 2023

Feat. M. Blinder
31:21
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Management of Hematologic Conditions in Athletes

Feat. R. Kasthuri
36:54
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Gene Therapy for Sickle Cell Disease: Are We Where They Wanted Us to…

Feat. A. Sharma
09:33
Nirmish Shah

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

19:35
The Blood Project

Exercises in CBC Interpretation: Sickle Cell Anemia

Feat. N. Bavli
08:11
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "A Novel Beta Globin Frameshift Mutation Cau…

Feat. L. Bilston
32:18
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Sickle Cell Disease 101

Feat. I. Osunkwo
13:57
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red …

Feat. K. Kuo
18:15
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Feat. S. Peslak
10:22
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

State-of-the-Art in Managing Thalassemias

Feat. M. Cappellini
33:17
Indy Hematology Review

Managing Benign Hematology Disorders

Feat. C. Kessler
48:27
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Sickle Cell Disease and Stroke

Feat. C. Fox
16:09
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

Feat. A. Taher
35:14
Moffitt Cancer Center

Moffitt Cancer Center Updates on Hemolytic Anemia

Feat. A. Canalejo, C. Leon
07:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Next-Generation HbS Polymerization Inhibito…

Feat. S. Saraf
17:17
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Myocardial Fibrosis in Sickle Cell Anemia&q…

Feat. J. Detterich
12:17
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Four Sickle Cell Game Changers

Feat. W. Hagar
26:27
University of Texas Southwestern Medical Center

Sickle Cell Disease: Old School vs New School

Feat. A. Nero
12:24
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

The Role of Luspatercept in Transfusion-Dependent Patients With Beta…

Feat. A. Tombak